Zoekresultaten - 1 result
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.
events were attributed to treatment with M/Clav. CONCLUSION: The rate of sustained successful treatment outcome observed here is far higher than the 26% observed in the 2014 World Health Organization XDR- ...